The PeerLINC Knowledge Hub, an innovative peer-to-peer initiative that connects experts from countries that rapidly adopted new six-month all-oral drug-resistant […]
2025 marks the 25th anniversary of TB Alliance. Throughout the year, we are sitting down with leaders and visionaries in
Stop TB Canada has announced a streamlined process to speed up the availability of pretomanid, a key drug in the
February 8th marks the 25th anniversary of the signing of the Cape Town Declaration, which birthed TB Alliance. Throughout the
Statement from TB Alliance on release of the G-FINDER 2024 Neglected Disease R&D Report NEW YORK (January 29, 2025)—The G-FINDER 2024 Neglected
Throughout 2024, one of TB Alliance’s foremost priorities has been ensuring that pretomanid and BPaL-based regimens reach all people with
BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health.
NEW YORK (December 9, 2024)—TB Alliance welcomes Srishti Gupta, MD, MPP, MPhil, and Akshay Vaishnaw, MB, BCh, PhD, FRCP, to
NEW YORK (November 6, 2024) — Macleods, a pharmaceutical company headquartered in India, has received prequalification from the World Health
New York (October 7, 2024) – TB Alliance is proud to announce a $7.35 million award through the U.S. Department
